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ABSTRACT : The prognosis of 63 patients with breast cancer was evaluated from 
the standpoint of node metastasis. In this series, the number and the location of involved 
node failed to assess precisely in association with the prognosis of patients with breast 
cancer. 
   Axillary node metastasis (Ax(+)) as well as parasternal node metastasis (ps(+)) was 
one of the most influential factors on the prognosis. However, it is emphasized that ps(+) 
dose not indicate the detrimental sign as far as dissection would be performed.
       INTRODUCTION 
 It is generally accepted that the outcome of 
surgical treatment is relatively fair when com-
pared with that of carcinomas of other organs. 
 In addition, it is believed that the survival time 
of surgical treatment in patients with breast 
cancer closely correlates with a presence of 
nodal involvement. 
 In this study, the most influential factors on 
the prognosis for breast cancer are evaluated 
in analysis of the survival rates according to 
TNM classification on the basis of a result of 
clinical experience with surgical treatments.
         PATIENTS 
 During the past 10 years from 1971 to 1980, 
63 patients with breast cancer were operated 
upon at the First Department of Surgery, 
Nagasaki University School of Medicine. Pre-
operative diagnosis was confirmed by means of 
aspiration needle biopsy or excisional biopsy 
among suspicious patients of breast cancer on 
palpation in combination with the findings of
mammography and echography. 
 According to TNM classification, eight pa-
tients belonged to Stage I, 42 were Stage II, eight 
were Stage IIIA and five were Stage IIIB, 
respectively. On the other hand, according to 
surgical stages, 31 patients belonged to stage 
I, 20 were stage II, eight were stage III and five 
were stage IV respectively. 
 A major discrepancy between TNM and 
trim-stages was probably due to the fact that 
palpable node swelling was not consistent with 
histologic node metastasis. 
 In this series, positive node metastasis in the 
axilla was confirmed in 26 patients whereas 
negative node metastasis was seen in 38 pa-
tients. 
 The survival times were compared between 
the patients with and without axillar node me-
tastasis. 
 Nine patients with PS(+) patients included 
in this study, eight patients out of whom had 
the tumor massess situated inside the breast 
(A and B area) and the other one had the tumor 
located in the center of the breast (A, E and C). 
 The survival times in patient with PS(+) were 
also compared with those in patients with ps(-).
          RESULTS 
 Figure 1 showed the survival time following 
surgery according to TNM classification. The 
survival times in stage I patients were almost 
the same as those in stage II.
 However, the survival times in stage IIIA and 
IIIB patients were apparently shortened as 
compared with those in stage I and 11, although 
those between stage IIIa and IIIB were almost 
similar. 
 On the other hand, according to tnm stage 
as shown in Figure 2, the survival times in stage
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I patients were apparently satisfactory as com-
pared with those in stage II patients. 
 On the other hand, the survival times in stage 
II patients resembled closely those in the stage 
III patiens. Those in stage IV patients were ob-
viously inferior to those in stage III. 
 Furthermore, the survival time in Ax(+) 
patients were compared with Ax(-) patients. 
These were apparently different as shown in 
Figure 3. Nodal involvement of the axillar region 
was closely correlated with the survival times 
following surgery. 
 Positive nodes in the axillar region showed 
that the survival curve rapidly declined two 
years following surgery and there was indicating 
a significant variation in the survival curves 
between Ax(+) and Ax(-) patients. 
 When compared between PS(-) and PS(+) 
patients, the survival curves were almost similar 
with those of AX(+) and Ax(+) patients as 
shown in Figure 4. 
 It was confirmed that ps(+) did not neces-
sarily imply poor outcome that was analogous 
to the result in Ax(+) patients. 
         DISCUSSION 
 There would be much debate on the question 
of influential factors of nodal involvement on 
the survival times. 
 Controversy exists concerning the therapeutic 
significance of nodal involvement of the axillar 
and the parasternal regions'' l'. 
 However, some investigators" 4' indicated that 
the survival times were more likely to relate to 
the number and the locaiton of involved nodes. 
It is not easy to precisely determine a presence 
of nodal involvement even though histologic 
examination had been performed. It is em-
phasized that the availability of monoclonal 
antibody and/or immunohistochemical method 
is indispensable for determination of node 
metastasis". In addition, it is often confirmed 
that even a presence of node metastasis, which 
fails to be certified by conventional histologic 
examination is defined by the use of monoclonal 
antibody or immunohistochemical staining. 
 Adair" reported that axillary node metastasis 
was the most influential factor on the prognosis 
of patients with breast cancer, more than the
sizes of the tumors. They investigated the 
prognosis of 1458 patients with breast cancer 
in a 30-year follow up period. Pertinent contro-
versial issues still remain unsolved, for ex-
ample, which is the most influential factor on 
the prognosis, the number of involved nodes or 
the locations'' '1'. 
 It is accepted that the prognosis of patients 
with node metastases less than three is much 
more fair than that of those with node me-
tastases more than four. 
 Veronesi et al" emphasized that it is necessary 
to divide the location of involved nodes into the 
three parts on the basis of the site of the minor 
pectoral muscle. Berg') also reported that as-
sessment of the prognosis of patients with 
breast cancer should be mode with respect of 
the sizes and the locations of involved nodes. 
On the other hand, Smith' clarified that there 
was no significant difference in the survival time 
between the locations of involved nodes when 
the number of involved node was equivalent. 
 Veronesi3' et al pointed out that a presence 
of involved node in the parasternal region af-
fects highly the prognosis of patients with breast 
cancer. 
 In this series, ps(+) is a simlar significance 
of the prognosis of patients with breast cancer 
with Ax(+). As reported by Noguchi9', confir-
mation of ps(+) should be performed by para-
sternal node biopsy in the first and the second 
intercostal spaces to avoid overlooking a pres-
ence of parasternal node metastasis.
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